{"content":"<li class=\"n-box-item date-title\" data-end=\"1498017599\" data-start=\"1497931200\" data-txt=\"Monday, December 23, 2019\">Tuesday, June 20, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3274661\" data-ts=\"1497998533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEF\" target=\"_blank\">TEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274661-america-movil-awaits-high-stakes-court-ruling-on-reforms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">America Movil awaits high-stakes court ruling on reforms</a></h4><ul>   <li>America Movil (<a href=\"http://seekingalpha.com/symbol/AMX\" target=\"_blank\">AMX</a> <font color='red'>-1.9%</font>) may get a ruling as soon as this month from Mexico's Supreme Court on its injunctions against 2013 telecom reforms that punished the company heavily and could <a href=\"https://www.bloomberg.com/news/articles/2017-06-20/america-movil-looks-for-800-million-reprieve-from-supreme-court\" target=\"_blank\">amount to an $800M swing</a>.</li>    <li>That's the amount in backlogged interconnection fees that rivals would have paid to America Movil had the reforms not eliminated those payments, in one issue before the court. It was a one-way change aimed at America Movil's dominance: Telefonica (NYSE:<a href='https://seekingalpha.com/symbol/TEF' title='Telefonica S.A.'>TEF</a>) and AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) still charge those fees to America Movil for incoming calls from its users.</li>    <li>America Movil says Congress didn't have the authority to single out the company for tougher penalties.</li>    <li>Mexico's highest court is headed toward a July 15 recess; if it doesn't rule on America Movil's injunctions by then, a decision would slip to later in the year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274661\" data-linked=\"America Movil awaits high-stakes court ruling on reforms\" data-tweet=\"$TEF $TEF $T - America Movil awaits high-stakes court ruling on reforms https://seekingalpha.com/news/3274661-america-movil-awaits-high-stakes-court-ruling-on-reforms?source=tweet\" data-url=\"https://seekingalpha.com/news/3274661-america-movil-awaits-high-stakes-court-ruling-on-reforms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274644\" data-ts=\"1497994548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274644-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a> <font color='green'>+10.6%</font>. <a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a> <font color='green'>+10.1%</font>. <a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a> <font color='green'>+7.3%</font>. <a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a> <font color='green'>+4.2%</font>. <a href='https://seekingalpha.com/symbol/CAF' title='Morgan Stanley China A Share Fund'>CAF</a> <font color='green'>+3.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/YPF' title='YPF Sociedad Anonima'>YPF</a> <font color='red'>-12.2%</font>. <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='red'>-6.1%</font>. <a href='https://seekingalpha.com/symbol/AGRO' title='Adecoagro S.A.'>AGRO</a> <font color='red'>-3.0%</font>. <a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-2.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274644\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$LZB $RHT $MDR - After Hours Gainers / Losers https://seekingalpha.com/news/3274644-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3274644-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274638\" data-ts=\"1497993124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274638-red-hat-beats-consensus-on-earnings-guidance-shares-up-9_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red Hat beats consensus on earnings, guidance; shares up 9.7%</a></h4><ul><li>        Red Hat (NYSE:<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a>) Q1 report beat EPS and revenue estimates. Subscription revenue was $597M, up 19% on the year. Deferred revenue was $2.05B at the end of the quarter, up 21%.</li><li>               Subscription revenue accounted for 88% of overall revenues and $458M of subscriptions came from Infrastructure-related offerings, a 14% growth on the year. Application Development-related and other emerging technologies accounted for the other $139M, a 41% growth.&nbsp;</li><li>               OCF was $258M for the quarter, up 11%. Total cash and equivalents were $2.31B after a $62M share repurchase.&nbsp;&nbsp;</li><li>               Q2 guidance: revenue between $695M and $702M compared to $677.42M consensus. EPS expected to come in around $0.67, two cents above consensus. Operating margin expected at 24%.&nbsp;</li><li>               FY18 guidance: revenue between $2.785B and $2.875B, above the $2.75B consensus, and $2.66 to $2.70 EPS with the low end coming in $0.03 above consensus. Operating margin expected at 23.6% and OCF between $850M and $870M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16867421-red-hat-reports-first-quarter-results-fiscal-year-2018\" target=\"_blank\">Press release</a>&nbsp;</li><li>               Red Hat shares are&nbsp;<font color='green'>up 9.72%</font>&nbsp;aftermarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274609-red-hat-beats-0_03-beats-revenue\" target=\"_blank\">Red Hat beats by $0.03, beats on revenue</a> (June 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274638\" data-linked=\"Red Hat beats consensus on earnings, guidance; shares up 9.7%\" data-tweet=\"$RHT - Red Hat beats consensus on earnings, guidance; shares up 9.7% https://seekingalpha.com/news/3274638-red-hat-beats-consensus-on-earnings-guidance-shares-up-9_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3274638-red-hat-beats-consensus-on-earnings-guidance-shares-up-9_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274636\" data-ts=\"1497992630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274636-sinclair-broadcast-group-shores-up-family-programming\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair Broadcast Group shores up family programming</a></h4><ul>   <li>Following an ambitious growth/merger plan that includes boosts to programming, local-TV titan Sinclair Broadcast Group (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color='red'>-5%</font>) has <a href=\"https://seekingalpha.com/pr/16867365-sinclair-names-dan-barnathan-vp-family-childrens-programming-sales-jonathan-dern-executive\" target=\"_blank\">set new leadership</a> in its unit overseeing children's/family programming.</li>    <li>The company named Daniel Barnathan its VP of Family and Children's Programming and Sales, and will launch \"KidsClick,\" a daily national program block, on Saturday, July 1.</li>    <li>Jonathan Dern was named executive producer for KidsClick, and Barnathan will have direct oversight. The block will be distributed to 75M U.S. homes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274636\" data-linked=\"Sinclair Broadcast Group shores up family programming\" data-tweet=\"$SBGI - Sinclair Broadcast Group shores up family programming https://seekingalpha.com/news/3274636-sinclair-broadcast-group-shores-up-family-programming?source=tweet\" data-url=\"https://seekingalpha.com/news/3274636-sinclair-broadcast-group-shores-up-family-programming\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274633\" data-ts=\"1497992259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LZB\" target=\"_blank\">LZB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274633-la-z-boyplus-11-after-easy-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">La-Z-Boy +11% after easy earnings beat</a></h4><ul>     <li>La-Z-Boy (NYSE:<a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a>) <font color='green'>+10.7%</font> AH after easily beating <a href=\"https://seekingalpha.com/news/3274611-la-z-boy-beats-0_11-beats-revenue\" target=\"_blank\">FQ4 earnings</a> expectations and increasing its stock buyback authorization.</li>     <li>LZB says all three business segments increased  their operating margins during the quarter, with the  upholstery segment margin of 13.5% the highest in more than a decade, and consolidated gross margin increased to 40.8% vs. 39.3% in the year-ago quarter.</li><li>The board approves the purchase of up to an additional 6M shares under the company's existing share  purchase authorization.</li><li>LZB notes the  furniture industry typically experiences weaker demand during the summer, so the upcoming FQ1 typically  is the company's weakest in sales and earnings.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274633\" data-linked=\"La-Z-Boy +11% after easy earnings beat\" data-tweet=\"$LZB - La-Z-Boy +11% after easy earnings beat https://seekingalpha.com/news/3274633-la-z-boyplus-11-after-easy-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3274633-la-z-boyplus-11-after-easy-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274632\" data-ts=\"1497992110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVO\" target=\"_blank\">NVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274632-fda-ad-comm-backs-cv-risk-claim-for-novos-victoza-shares-ahead-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA Ad Comm backs CV risk claim for Novo&#39;s Victoza; shares ahead 1% after hours</a></h4><ul><li>Novo Nordisk (NYSE:<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;after hours on average volume on the heels of a positive vote by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee that VICTOZA (liraglutide) reduces the risk of major cardiac events in high-risk type 2 diabetics. Votes:</li><li>17 - 2 in favor that the company provided substantial evidence that liraglutide reduces CV risk.</li><li>19 - 0 that liraglutide is not associated with unacceptably high CV risk.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274020-fda-advisory-committee-meet-june-20-review-novos-application-seeking-approval-cv-risk\" target=\"_blank\">FDA advisory committee to meet June 20 to review Novo's application seeking approval to CV risk reduction claim to Victoza label; shares up 1%</a> (June 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274632\" data-linked=\"FDA Ad Comm backs CV risk claim for Novo&#39;s Victoza; shares ahead 1% after hours\" data-tweet=\"$NVO - FDA Ad Comm backs CV risk claim for Novo&#39;s Victoza; shares ahead 1% after hours https://seekingalpha.com/news/3274632-fda-ad-comm-backs-cv-risk-claim-for-novos-victoza-shares-ahead-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3274632-fda-ad-comm-backs-cv-risk-claim-for-novos-victoza-shares-ahead-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274629\" data-ts=\"1497991736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274629-china-shares-make-msci-cut-china-etfs-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China A shares make the MSCI cut; China ETFs gain</a></h4><ul><li><a href=\"https://www.msci.com/\" target=\"_blank\">MSCI will include</a> China's A shares in the MSCI Emerging Markets Index.</li><li>Deutsche X-Trackers Harvest CSI 300 China A-Shares ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/ASHR' title='Deutsche X-trackers Harvest CSI 300 China A-Shares ETF'>ASHR</a>)&nbsp;<font color='green'>+2%</font>&nbsp;after hours.</li><li>iShares FTSE/Xinhua China 25 Index (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXI' title='iShares China Large-Cap ETF'>FXI</a>)&nbsp;<font color='green'>+0.4%</font>.</li><li>A-shares ETFs: <a href='https://seekingalpha.com/symbol/ASHR' title='Deutsche X-trackers Harvest CSI 300 China A-Shares ETF'>ASHR</a>, <a href='https://seekingalpha.com/symbol/CAF' title='Morgan Stanley China A Share Fund'>CAF</a>, <a href='https://seekingalpha.com/symbol/PEK' title='VanEck Vectors ChinaAMC CSI 300 ETF'>PEK</a>, <a href='https://seekingalpha.com/symbol/KBA' title='KraneShares Bosera MSCI China A ETF'>KBA</a>, <a href='https://seekingalpha.com/symbol/ASHS' title='Deutsche X-trackers Harvest CSI 500 China-A Shares Small Cap ETF'>ASHS</a>, <a href='https://seekingalpha.com/symbol/CNXT' title='VanEck Vectors ChinaAMC SME-ChiNext ETF'>CNXT</a>, <a href='https://seekingalpha.com/symbol/CHAU' title='Direxion Daily CSI 300 China A Share Bull 2x Shares ETF'>CHAU</a>, <a href='https://seekingalpha.com/symbol/CHAD' title='Direxion Daily CSI 300 China A Share Bear 1x Shares ETF'>CHAD</a>, <a href='https://seekingalpha.com/symbol/AFTY' title='CSOP FTSE China A50 ETF'>AFTY</a>, <a href='https://seekingalpha.com/symbol/ASHX' title='Deutsche X-trackers CSI 300 China A-Shares Hedged Equity ETF'>ASHX</a>, <a href='https://seekingalpha.com/symbol/CNYA' title='iShares MSCI China A ETF'>CNYA</a>, <a href='https://seekingalpha.com/symbol/HAHA' title='CSOP China CSI 300 A-H Dynamic ETF'>HAHA</a>, <a href='https://seekingalpha.com/symbol/CNHX' title='CSOP MSCI China A International Hedged ETF'>CNHX</a>, <a href='https://seekingalpha.com/symbol/XINA' title='SPDR MSCI China A Shares IMI ETF'>XINA</a></li><li>Broad China ETFs: <a href='https://seekingalpha.com/symbol/FXI' title='iShares China Large-Cap ETF'>FXI</a>, <a href='https://seekingalpha.com/symbol/YINN' title='Direxion Daily FTSE China Bull 3x Shares ETF'>YINN</a>, <a href='https://seekingalpha.com/symbol/YANG' title='Direxion Daily FTSE China Bear 3x Shares ETF'>YANG</a>, <a href='https://seekingalpha.com/symbol/GXC' title='SPDR S&P China ETF'>GXC</a>, <a href='https://seekingalpha.com/symbol/FXP' title='ProShares UltraShort FTSE China 25 ETF'>FXP</a>, <a href='https://seekingalpha.com/symbol/PGJ' title='PowerShares Golden Dragon China Portfolio ETF'>PGJ</a>, <a href='https://seekingalpha.com/symbol/MCHI' title='iShares MSCI China ETF'>MCHI</a>, <a href='https://seekingalpha.com/symbol/CHN' title='China Fund'>CHN</a>, <a href='https://seekingalpha.com/symbol/TDF' title='Templeton Dragon Fund'>TDF</a>, <a href='https://seekingalpha.com/symbol/XPP' title='ProShares Ultra FTSE China 25 ETF'>XPP</a>, <a href='https://seekingalpha.com/symbol/YXI' title='ProShares Short FTSE China 50 ETF'>YXI</a>, <a href='https://seekingalpha.com/symbol/CN' title='Deutsche X-trackers Harvest MSCI All China Equity ETF'>CN</a>, <a href='https://seekingalpha.com/symbol/FCA' title='First Trust China AlphaDEX ETF'>FCA</a>, <a href='https://seekingalpha.com/symbol/YAO' title='Guggenheim China All-Cap ETF'>YAO</a>, <a href='https://seekingalpha.com/symbol/GCH' title='Greater China Fund'>GCH</a>, <a href='https://seekingalpha.com/symbol/CXSE' title='WisdomTree China ex-State-Owned Enterprises ETF'>CXSE</a>, <a href='https://seekingalpha.com/symbol/JFC' title='JPMorgan China Region Fund, Inc.'>JFC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274629\" data-linked=\"China A shares make the MSCI cut; China ETFs gain\" data-tweet=\"$ASHR $FXI $CAF - China A shares make the MSCI cut; China ETFs gain https://seekingalpha.com/news/3274629-china-shares-make-msci-cut-china-etfs-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3274629-china-shares-make-msci-cut-china-etfs-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274623\" data-ts=\"1497991075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274623-oil-inventory-down-2_7m-barrels-last-week-api\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil inventory down 2.7M barrels last week - API</a></h4><ul><li>That amount would be about double the decline expected when the EIA releases its inventory numbers tomorrow morning.</li><li>Oil's not doing a lot on the print, still&nbsp;<font color='red'>off 2%</font>&nbsp;for the session and at a nine-month low of $43.55 per barrel.</li><li><a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> flat after hours</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274623\" data-linked=\"Oil inventory down 2.7M barrels last week - API\" data-tweet=\"$USO $OIL $UWT - Oil inventory down 2.7M barrels last week - API https://seekingalpha.com/news/3274623-oil-inventory-down-2_7m-barrels-last-week-api?source=tweet\" data-url=\"https://seekingalpha.com/news/3274623-oil-inventory-down-2_7m-barrels-last-week-api\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274622\" data-ts=\"1497991057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274622-chinese-investor-backs-off-30m-investment-in-pluristem-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese investor backs off $30M investment in Pluristem; shares down 4% after hours</a></h4><ul><li>In a regulatory filing, Pluristem (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1158780/000117891317001864/zk1720162.htm\" target=\"_blank\">reports </a>that, due to a recently adopted Chinese policy governing outbound investments by Chinese firms, Innovative Medical Management Co., Ltd., has terminated its plans to invest $30M in the company.</li><li>Shares are down&nbsp;<font color='red'>4%</font>&nbsp;after hours on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3232376-pluristem-innovative-medical-extends-execution-agreements-due-new-chinese-monetary-policy\" target=\"_blank\">Pluristem and Innovative Medical extends execution of agreements due to new Chinese Monetary Policy</a> (Dec. 23, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274622\" data-linked=\"Chinese investor backs off $30M investment in Pluristem; shares down 4% after hours\" data-tweet=\"$PSTI - Chinese investor backs off $30M investment in Pluristem; shares down 4% after hours https://seekingalpha.com/news/3274622-chinese-investor-backs-off-30m-investment-in-pluristem-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3274622-chinese-investor-backs-off-30m-investment-in-pluristem-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274620\" data-ts=\"1497990628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDOC\" target=\"_blank\">TDOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274620-teladoc-readies-200m-convertible-debt-offering-shares-slip-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teladoc readies $200M convertible debt offering; shares slip 2% after hours</a></h4><ul><li>Teladoc (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) eases&nbsp;<font color='red'>2%</font>&nbsp;after hours on light volume in response to its <a href=\"https://seekingalpha.com/pr/16867435-teladoc-announces-proposed-offering-200-million-convertible-senior-notes-due-2022\" target=\"_blank\">planned $200M private offering</a> of Convertible Senior Notes due 2022. Initial buyers will have the option to purchase up to an additional $30M of the Notes. Price and terms have yet to be announced.</li><li>Net proceeds will fund part of the company's acquisition of Best Doctors Holdings, the refinancing of existing debt, working capital and general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274620\" data-linked=\"Teladoc readies $200M convertible debt offering; shares slip 2% after hours\" data-tweet=\"$TDOC - Teladoc readies $200M convertible debt offering; shares slip 2% after hours https://seekingalpha.com/news/3274620-teladoc-readies-200m-convertible-debt-offering-shares-slip-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3274620-teladoc-readies-200m-convertible-debt-offering-shares-slip-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274619\" data-ts=\"1497990302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274619-adobe-q2-beats-estimates-shares-up-3_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe Q2 beats estimates; shares up 3.5%</a></h4><ul><li>        Adobe Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) Q2 report beat EPS and revenue estimates. The Digital Media segment had sales of $1.21B, Creative segment reported $1.01B, and the Adobe Experience Cloud posted $495M in revenue, up 29% on the year. &nbsp;</li><li>        General segment sales: Subscription: $1.4B; Product: $171.5M; Services and support: $117M.</li><li>           Cash flow from operations was $645M with deferred revenue up to $2.07B.&nbsp; </li><li><a href=\"https://seekingalpha.com/pr/16867402-adobe-achieves-record-revenue\" target=\"_blank\">     Press release&nbsp;</a></li><li>Adobe shares are&nbsp;<font color='green'>up 3.54%</font>&nbsp;aftermarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274600-adobe-systems-beats-0_07-beats-revenue\" target=\"_blank\">Adobe Systems beats by $0.07, beats on revenue</a> (June 20)</li></ul> &nbsp;<br /><div class=\"tiny-share-widget\" data-id=\"3274619\" data-linked=\"Adobe Q2 beats estimates; shares up 3.5%\" data-tweet=\"$ADBE - Adobe Q2 beats estimates; shares up 3.5% https://seekingalpha.com/news/3274619-adobe-q2-beats-estimates-shares-up-3_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3274619-adobe-q2-beats-estimates-shares-up-3_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274618\" data-ts=\"1497990294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274618-fedex-higher-after-profit-smasher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx higher after profit smasher</a></h4><ul> <li>FedEx (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>) crushes FQ4 profit estimates as higher base rates and package volume helped to lift margin rates.</li> <li>The express segment brought in revenue of $7.18B and operating income of $909M.</li> <li>The TNT business delivered revenue of $1.91B and operating income of $83M.</li> <li>The ground segment saw revenue of $4.68B and operating income of $702M.</li><li>The company expects full-year EPS of $13.20 to $14.00 (excluding TNT Express results) vs. $13.61 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274607-fedex-beats-0_37-beats-revenue\" target=\"_blank\">FedEx beats by $0.37, beats on revenue</a> (June 20)</li> <li>Shares of FedEx are <font color='green'>up 1.94% </font>AH to $213.00. That marks tops the intraday all-time high of $211.88.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3274618\" data-linked=\"FedEx higher after profit smasher\" data-tweet=\"$FDX - FedEx higher after profit smasher https://seekingalpha.com/news/3274618-fedex-higher-after-profit-smasher?source=tweet\" data-url=\"https://seekingalpha.com/news/3274618-fedex-higher-after-profit-smasher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274612\" data-ts=\"1497989950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274612-sangamo-readies-equity-offering-shares-down-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo readies equity offering; shares down 8% after hours</a></h4><ul><li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) slumps&nbsp;<font color='red'>8%</font>&nbsp;after hours on average volume in response to its <a href=\"https://seekingalpha.com/pr/16867394-sangamo-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">planned public offering</a> of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274612\" data-linked=\"Sangamo readies equity offering; shares down 8% after hours\" data-tweet=\"$SGMO - Sangamo readies equity offering; shares down 8% after hours https://seekingalpha.com/news/3274612-sangamo-readies-equity-offering-shares-down-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3274612-sangamo-readies-equity-offering-shares-down-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274611\" data-ts=\"1497989877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LZB\" target=\"_blank\">LZB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274611-la-z-boy-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">La-Z-Boy beats by $0.11, beats on revenue</a></h4><ul><li>La-Z-Boy (NYSE:<a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a>): Q4 EPS of $0.57 <font color='green'>beats by $0.11</font>.</li><li>Revenue of $412.7M (-1.0% Y/Y) <font color='green'>beats by $12.45M</font>.</li><li>Shares <font color='green'>+2.4%</font>.</li><li><a href='https://seekingalpha.com/pr/16867422-la-z-boy-reports-fiscal-2017-full-year-fourth-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274611\" data-linked=\"La-Z-Boy beats by $0.11, beats on revenue\" data-tweet=\"$LZB - La-Z-Boy beats by $0.11, beats on revenue https://seekingalpha.com/news/3274611-la-z-boy-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3274611-la-z-boy-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274609\" data-ts=\"1497989824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274609-red-hat-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red Hat beats by $0.03, beats on revenue</a></h4><ul><li>Red Hat (NYSE:<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a>): Q1 EPS of $0.56 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $676.8M (+19.2% Y/Y) <font color='green'>beats by $28.96M</font>.</li><li>Shares <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/pr/16867421-red-hat-reports-first-quarter-results-fiscal-year-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274609\" data-linked=\"Red Hat beats by $0.03, beats on revenue\" data-tweet=\"$RHT - Red Hat beats by $0.03, beats on revenue https://seekingalpha.com/news/3274609-red-hat-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3274609-red-hat-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274607\" data-ts=\"1497989752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274607-fedex-beats-0_37-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx beats by $0.37, beats on revenue</a></h4><ul><li>FedEx (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>): Q4 EPS of $4.25 <font color='green'>beats by $0.37</font>.</li><li>Revenue of $15.7B (+21.0% Y/Y) <font color='green'>beats by $140M</font>.</li><li>Shares <font color='green'>+1.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16867416-fedex-corp-reports-record-fourth-quarter-full-year-earnings'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274607\" data-linked=\"FedEx beats by $0.37, beats on revenue\" data-tweet=\"$FDX - FedEx beats by $0.37, beats on revenue https://seekingalpha.com/news/3274607-fedex-beats-0_37-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3274607-fedex-beats-0_37-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274600\" data-ts=\"1497989154\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274600-adobe-systems-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe Systems beats by $0.07, beats on revenue</a></h4><ul><li>Adobe Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>): Q2 EPS of $1.02 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $1.77B (+26.4% Y/Y) <font color='green'>beats by $40M</font>.</li><li>Shares <font color='green'>+2%</font>.</li><li><a href='https://seekingalpha.com/pr/16867402-adobe-achieves-record-revenue'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274600\" data-linked=\"Adobe Systems beats by $0.07, beats on revenue\" data-tweet=\"$ADBE - Adobe Systems beats by $0.07, beats on revenue https://seekingalpha.com/news/3274600-adobe-systems-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3274600-adobe-systems-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274594\" data-ts=\"1497988692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGN\" target=\"_blank\">EGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274594-energen-boosts-production-view-ends-strategic-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energen boosts production view, ends strategic review</a></h4><ul>     <li>Energen (<a href='https://seekingalpha.com/symbol/EGN' title='Energen Corporation'>EGN</a> <font color='red'>-4.1%</font>) is lower despite <a href=\"https://seekingalpha.com/filing/3599017\" target=\"_blank\">raising its FY 2017 production outlook</a> and ending its strategic review.</li><li>Citing the strength of results from wells completed with its Generation 3 frac design, EGN raises its total 2017 production estimate to 70.2K boe/day, or 5.9% higher than prior guidance, which would bring its Y/Y production growth to 29% vs. a prior outlook for a 21%&nbsp;gain.</li><li>Drilling  and development capital spending guidance for the full year remains unchanged at  $850M-$900M.</li><li>Citing the strong performance, EGN's board says continuing to execute  its current business plan is the best path to enhancing shareholder  value.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274594\" data-linked=\"Energen boosts production view, ends strategic review\" data-tweet=\"$EGN - Energen boosts production view, ends strategic review https://seekingalpha.com/news/3274594-energen-boosts-production-view-ends-strategic-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3274594-energen-boosts-production-view-ends-strategic-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274589\" data-ts=\"1497987699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274589-windstream-holdingsminus-6_7-to-all-time-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream Holdings -6.7% to all-time low</a></h4><ul>    <li>Windstream Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>) has <font color='red'>slipped 6.7%</font> to an all-time low, on above-average volume and no news in particular.</li>    <li>The forward yield on the dividend is up to 13.4%, though this year the stock is underperforming rival CenturyLink (<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a> <font color='red'>down 42.7%</font> in 2017, vs. <a href='https://seekingalpha.com/symbol/CTL' title='CenturyLink, Inc.'>CTL</a> <font color='green'>up 3.9%</font>).</li><li>Frontier Communications (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) is <font color='red'>off 9.8%</font>, while <a href='https://seekingalpha.com/symbol/CTL' title='CenturyLink, Inc.'>CTL</a> is <font color='red'>2.6% lower</font>.</li>    <li>Last week the company announced it was extending gigabit service into North Georgia, making Georgia one of the first five states in its footprint to get gigabit access.</li>    <li>Gigabit service is also available from the company in Nebraska, Kentucky, Texas, and North Carolina.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274589\" data-linked=\"Windstream Holdings -6.7% to all-time low\" data-tweet=\"$WIN $WINMQ $CTL - Windstream Holdings -6.7% to all-time low https://seekingalpha.com/news/3274589-windstream-holdingsminus-6_7-to-all-time-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3274589-windstream-holdingsminus-6_7-to-all-time-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274588\" data-ts=\"1497987610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274588-barclays-warns-on-second-half-u-s-box-office-slowdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays warns on second-half U.S box office slowdown</a></h4><ul> <li>A biting note from Barclays appears to be behind the slide in theater stocks today.</li> <li>Barclays singles out AMC Entertainment AMC with a price target cut to $31, but also warns of broader pressure for the industry in Q3 and Q4. A heavy reliance on Disney for mega-hits (25% of domestic box) is seen as a negative factor.</li> <li>Decliners include AMC Entertainment (<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a> <font color='red'>-5.5%</font>), IMAX (<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a> <font color='red'>-2.4%</font>), Cinemark (<a href='https://seekingalpha.com/symbol/CNK' title='Cinemark Holdings, Inc'>CNK</a> <font color='red'>-2.9%</font>), Regal Entertainment (<a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a> <font color='red'>-2.8%</font>) and digital advertising firm National CineMedia (<a href='https://seekingalpha.com/symbol/NCMI' title='National CineMedia, Inc.'>NCMI</a> <font color='red'>-1.1%</font>).</li> <li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274503-movie-theater-stocks-sluggish-amid-broad-retail-concerns\" target=\"_blank\">Movie theater stocks sluggish amid broad retail concerns</a> (June 20)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3274588\" data-linked=\"Barclays warns on second-half U.S box office slowdown\" data-tweet=\"$AMC $AMC $IMAX - Barclays warns on second-half U.S box office slowdown https://seekingalpha.com/news/3274588-barclays-warns-on-second-half-u-s-box-office-slowdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3274588-barclays-warns-on-second-half-u-s-box-office-slowdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274587\" data-ts=\"1497987480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXY\" target=\"_blank\">OXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274587-occidental-petroleum-tumble-another-20-barclays-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Occidental Petroleum could tumble another 20%, Barclays says</a></h4><ul>     <li>Shares of Occidental Petroleum (<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a> <font color='red'>-2%</font>), already a big underperformer relative to oil and gas peers, <a href=\"http://www.barrons.com/articles/why-occidental-petroleum-could-tumble-20-1497983163\" target=\"_blank\">could drop another ~20%</a>, Barclays analysts contend as they reiterate their Underweight rating while cutting the price target to $48 from $50.</li>     <li>Count the ways Barclays does not like OXY: Shares lagged the S&amp;P E&amp;P Index by ~10% over the past year, OXY&rsquo;s production compared to capital deployed is expected to will shrink ~17% in 2016-17, and the stock's relative multiple has expanded, making it the most expensive company the firm covers as a ratio of eneterprise value to estimated 2018 cash flow.</li>     <li>While some would argue that OXY is not a pure E&amp;P company, Barclays says it has traded much like an E&amp;P company and estimates ~70% of its value comes from E&amp;P assets, not far below the 80-85% the firm attributes to Anadarko Petroleum (<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color='red'>-0.7%</font>) or Devon Energy (<a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a> <font color='red'>-0.4%</font>) E&amp;P assets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274587\" data-linked=\"Occidental Petroleum could tumble another 20%, Barclays says\" data-tweet=\"$OXY $OXY $APC - Occidental Petroleum could tumble another 20%, Barclays says https://seekingalpha.com/news/3274587-occidental-petroleum-tumble-another-20-barclays-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3274587-occidental-petroleum-tumble-another-20-barclays-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274585\" data-ts=\"1497986505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274585-ges-aviation-business-likely-to-stay-through-coming-revamp-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE&#39;s aviation business likely to stay through coming revamp, analyst says</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-2.1%</font>) is today's worst performer on the Dow Jones index, and has given back nearly all the gains amassed following the announcement of CEO&nbsp;Jeffrey Immelt's upcoming <a href=\"https://seekingalpha.com/news/3272802-general-electric-ceo-stepping\" target=\"_blank\">departure</a>.</li>     <li>As speculation swirls about which parts of the company could stay or leave, Credit Suisse's Julian Mitchell says <a href=\"http://www.barrons.com/articles/general-electric-can-aviation-make-it-fly-1497974250\" target=\"_blank\">the aviation business likely will stick around</a>, as it represents a third of GE's earnings and has been the biggest segment EBIT growth driver for GE in recent years, growing profits at a double-digit rate in each of the past four years.</li><li>Credit Suisse says Aviation's share of GE profits likely will expand as other assets eventually exit, which should be helpful for the valuation of the overall company, given Aviation's high profitability and cash margin levels.</li>     <li><a href=\"https://seekingalpha.com/news/3273903-barclays-ges-airplane-leasing-business-fantastic-underappreciated-asset\" target=\"_blank\">Previously</a>: Barclays: GE's airplane leasing business a \"fantastic,\" underappreciated asset. (June 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274585\" data-linked=\"GE&#39;s aviation business likely to stay through coming revamp, analyst says\" data-tweet=\"$GE - GE&#39;s aviation business likely to stay through coming revamp, analyst says https://seekingalpha.com/news/3274585-ges-aviation-business-likely-to-stay-through-coming-revamp-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3274585-ges-aviation-business-likely-to-stay-through-coming-revamp-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274582\" data-ts=\"1497985345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274582-cowen-drops-profit-estimates-on-nike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen drops profit estimates on Nike</a></h4><ul> <li>Cowen lowers estimates on Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='red'>-1.6%</font>) as it warns on consensus marks that are too high. The firm now <a href=\"http://www.barrons.com/articles/nike-running-out-of-room-1497977910\" target=\"_blank\">expects</a> Nike to generate FY18 EPS of $2.41 vs. $2.51 consensus and FY19 EPS of $2.57 vs. $2.89 consensus.</li> <li>\"Our checks show elevated promotions continue on footwear (basketball, running and lifestyle) and apparel throughout N. America (45% of sales) which also coincides with a more promotional cadence from UAA and Adidas,\" updates analyst John Kernan.</li> <li>Shares of Nike are down 13% over the last 90 days and trade about 15% below their 52-week high.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3274582\" data-linked=\"Cowen drops profit estimates on Nike\" data-tweet=\"$NKE - Cowen drops profit estimates on Nike https://seekingalpha.com/news/3274582-cowen-drops-profit-estimates-on-nike?source=tweet\" data-url=\"https://seekingalpha.com/news/3274582-cowen-drops-profit-estimates-on-nike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274580\" data-ts=\"1497985207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274580-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CYBE' title='CyberOptics Corporation'>CYBE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SSNI' title='Silver Spring Networks'>SSNI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274580\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$VSLR $RUN $CYBE - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3274580-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3274580-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274578\" data-ts=\"1497984645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PE\" target=\"_blank\">PE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274578-parsley-energy-rises-after-raising-production-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Parsley Energy rises after raising production guidance</a></h4><ul><li>Parsley Energy (<a href='https://seekingalpha.com/symbol/PE' title='Parsley Energy, Inc.'>PE</a> <font color='green'>+1.7%</font>) is one of the few oil and gas companies showing a gain today after providing FY 2017 production guidance in an <a href=\"http://s21.q4cdn.com/387064974/files/doc_presentations/2017/PE-Investor-Presentation_June-2017_Wells-Fargo-Conference-%281%29.pdf\" target=\"_blank\">investor presentation</a>.</li><li>PE sees 2017 production of 65K-71K boe/day, better than prior guidance of 62K-68K boe/day, including estimated Q4 output of 78K-88K boe/day vs. an earlier outlook of 75K-85K.</li><li>PE maintains guidance for drilling capital spending of $840M-$960M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274578\" data-linked=\"Parsley Energy rises after raising production guidance\" data-tweet=\"$PE - Parsley Energy rises after raising production guidance https://seekingalpha.com/news/3274578-parsley-energy-rises-after-raising-production-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3274578-parsley-energy-rises-after-raising-production-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274574\" data-ts=\"1497982879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSLR\" target=\"_blank\">VSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274574-vivint-solarplus-18-after-goldman-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivint Solar +18% after Goldman upgrade</a></h4><ul>     <li>Vivint Solar (<a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='green'>+17.8%</font>) is nearly 20% higher after Goldman Sachs <a href=\"https://www.fool.com/investing/2017/06/20/why-vivint-solar-incs-shares-popped-22-today.aspx\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $6 price target, lifted from $3.50.</li>     <li>Goldman sees VSLR as an excellent takeover target as financing for renewable projects and M&amp;A improves, and believes the company's move to cash and loan sales will improve its business.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274574\" data-linked=\"Vivint Solar +18% after Goldman upgrade\" data-tweet=\"$VSLR - Vivint Solar +18% after Goldman upgrade https://seekingalpha.com/news/3274574-vivint-solarplus-18-after-goldman-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3274574-vivint-solarplus-18-after-goldman-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274567\" data-ts=\"1497980062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMGN\" target=\"_blank\">IMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274567-immunogen-follows-up-on-yesterdays-up-move-shares-ahead-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoGen follows up on yesterday&#39;s up move, shares ahead 13%</a></h4><ul><li>ImmunoGen (<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+13.2%</font>) is up on almost double normal volume. Shares have rallied almost&nbsp;<font color='green'>25%</font>&nbsp;over the past three sessions.</li><li>Yesterday, Leerink analyst Michael Schmidt <a href=\"https://www.investorvillage.com/smbd.asp?mb=1316&amp;mn=46305&amp;pt=msg&amp;mid=17276029\" target=\"_blank\">reiterated </a>his Outperform rating and boosted the price target to $11 from $8 citing a lower cost of capital from the divestment of non-core ADC assets.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3269417-immunogen-divests-adc-candidate-debiopharm-much-55m-shares-4-percent-hours\" target=\"_blank\">ImmunoGen divests ADC candidate to Debiopharm for as much as $55M; shares up 4% after hours</a> (May 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274567\" data-linked=\"ImmunoGen follows up on yesterday&#39;s up move, shares ahead 13%\" data-tweet=\"$IMGN - ImmunoGen follows up on yesterday&#39;s up move, shares ahead 13% https://seekingalpha.com/news/3274567-immunogen-follows-up-on-yesterdays-up-move-shares-ahead-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3274567-immunogen-follows-up-on-yesterdays-up-move-shares-ahead-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274564\" data-ts=\"1497979316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274564-arena-continues-up-move-shares-ahead-25-in-three-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena continues up move, shares ahead 25% in three days</a></h4><ul><li>Thinly traded nano cap Arena Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a> <font color='green'>+10.1%</font>) is up on more than double normal volume. Shares have rallied over&nbsp;<font color='green'>25%</font>&nbsp;over the past three sessions ahead of tomorrow's <a href=\"https://seekingalpha.com/pr/16862949-arena-pharmaceuticals-present-jmp-securities-life-sciences-conference\" target=\"_blank\">presentation </a>at the JMP Securities Life Sciences Conference in New York.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274564\" data-linked=\"Arena continues up move, shares ahead 25% in three days\" data-tweet=\"$ARNA - Arena continues up move, shares ahead 25% in three days https://seekingalpha.com/news/3274564-arena-continues-up-move-shares-ahead-25-in-three-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3274564-arena-continues-up-move-shares-ahead-25-in-three-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274563\" data-ts=\"1497979097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXP\" target=\"_blank\">AXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274563-amex-roundup-shares-outperform-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmEx roundup: Shares outperform after upgrade</a></h4><ul><li>Not seeing any sizable negative catalysts in the near-term, analyst Vincent Caintic at Stephens pulls his Underweight rating and lifts his price target to $82 (inline with current price) from $70.</li><li>In other news, American Express (NYSE:<a href='https://seekingalpha.com/symbol/AXP' title='American Express Company'>AXP</a>) gets its foot in possible insurance sector disruption out of Silicon Valley, <a href=\"https://www.reuters.com/article/us-american-express-investment-idUSKBN19B29R\" target=\"_blank\">with an investment in Next Insurance</a> - a startup selling customized insurance to small businesses online. AmEx is part of a $35M investment round, and it and Next are in early talks about a possible partnership leveraging the card player's massive base of U.S. businesses.</li><li>Shares&nbsp;<font color='green'>+0.9%</font>&nbsp;vs. small declines for Capital One and Discover.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274563\" data-linked=\"AmEx roundup: Shares outperform after upgrade\" data-tweet=\"$AXP - AmEx roundup: Shares outperform after upgrade https://seekingalpha.com/news/3274563-amex-roundup-shares-outperform-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3274563-amex-roundup-shares-outperform-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274561\" data-ts=\"1497978676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XELB\" target=\"_blank\">XELB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274561-apparel-stocks-clipped-after-amazon-previews-fashion-concept\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apparel stocks clipped after Amazon previews fashion concept</a></h4><ul> <li>The apparel sector is underperforming the broad market after Amazon unleashes details about its Prime Warehouse program that allows members to try on clothes before buying them.</li> <li>The leading decliners off the news are Xcel Brands (<a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='red'>-3.6%</font>), Perry Ellis International (<a href='https://seekingalpha.com/symbol/PERY' title='Perry Ellis International Inc.'>PERY</a> <font color='red'>-3.3%</font>), Columbia Sportswear (<a href='https://seekingalpha.com/symbol/COLM' title='Columbia Sportswear Company'>COLM</a> <font color='red'>-3.5%</font>), G-III Apparel (<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='red'>-3.1%</font>), V.F. Corporation (<a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a> <font color='red'>-3.3%</font>), Ascena Retail group (<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='red'>-7%</font>), Tailored Brands (<a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a> <font color='red'>-7.8%</font>), Tilly's (<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='red'>-5.2%</font>) and J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='red'>-5.3%</font>).</li> <li>The SPDR S&amp;P Retail ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>) is <font color='red'>down 1.69%,</font> and is now off 3.73% since Amazon acquired Whole Foods on Friday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274528-fashion-play-coming-amazon\" target=\"_blank\">Fashion play coming from Amazon</a> (June 20)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3274561\" data-linked=\"Apparel stocks clipped after Amazon previews fashion concept\" data-tweet=\"$XELB $XELB $PERY - Apparel stocks clipped after Amazon previews fashion concept https://seekingalpha.com/news/3274561-apparel-stocks-clipped-after-amazon-previews-fashion-concept?source=tweet\" data-url=\"https://seekingalpha.com/news/3274561-apparel-stocks-clipped-after-amazon-previews-fashion-concept\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274560\" data-ts=\"1497978617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274560-financials-top-5-gainers-losers-of-1-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:10 PM</a></h4><ul><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CUBN' title='Commerce Union Bancshares, Inc. &#40;Springfield TN&#41;'>CUBN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='red'>-5%.</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3274560\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:10 PM\" data-tweet=\"$CUBN $OCN - Financials - Top 5 Gainers / Losers as of 1:10 PM https://seekingalpha.com/news/3274560-financials-top-5-gainers-losers-of-1-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3274560-financials-top-5-gainers-losers-of-1-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274553\" data-ts=\"1497977525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIMT\" target=\"_blank\">AIMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274553-aimmune-up-5-on-preliminary-screening-data-in-late-stage-study-of-ar101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aimmune up 5% on preliminary screening data in late-stage study of AR101</a></h4><ul><li>Thinly traded small cap Aimmune Therapeutics (<a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics'>AIMT</a> <font color='green'>+4.7%</font>) builds on yesterday's&nbsp;<font color='green'>7%</font>&nbsp;reversal on light volume. Investors appear to be reacting to <a href=\"https://seekingalpha.com/pr/16866140-aimmune-therapeutics-presents-european-phase-3-palisade-screening-data-2017-european-academy\" target=\"_blank\">preliminary clinical data</a> presented at the European Academy of Allergy and Clinical Immunology Congress in Helsinki from a late-stage study of peanut allergy candidate AR101.</li><li>In a preliminary dataset of 166 European patients who underwent a food challenge to determine eligibility for the Phase 3 PALISADE trial, 62% (n=103/166) were \"reactors\" who experienced dose-limiting symptoms. They had statistically significantly larger peanut skin-prick test wheal diameters, higher peanut-specific IgE and higher Ara h 2-specific IgE than non-reactors.</li><li>The company says this information will help it determine the best use of AR101 on a large scale.</li><li><a href=\"http://www.aimmune.com/pipeline/\" target=\"_blank\">AR101</a>&nbsp;is an orally administered biologic that desensitizes patients with peanut allergy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274553\" data-linked=\"Aimmune up 5% on preliminary screening data in late-stage study of AR101\" data-tweet=\"$AIMT - Aimmune up 5% on preliminary screening data in late-stage study of AR101 https://seekingalpha.com/news/3274553-aimmune-up-5-on-preliminary-screening-data-in-late-stage-study-of-ar101?source=tweet\" data-url=\"https://seekingalpha.com/news/3274553-aimmune-up-5-on-preliminary-screening-data-in-late-stage-study-of-ar101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274555\" data-ts=\"1497977186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274555-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+190%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/AHPI' title='Allied Healthcare Products, Inc.'>AHPI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NK' title='NantKwest'>NK</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/EVI' title='EnviroStar, Inc.'>EVI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FLGT' title='Fulgent Genetics'>FLGT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/ONS-OLD' title='Oncobiologics'>ONS-OLD</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SKYS' title='Sky Solar Holdings'>SKYS</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274555\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$DCTH $SGOC $VSLR - Midday Gainers / Losers https://seekingalpha.com/news/3274555-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3274555-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274554\" data-ts=\"1497976848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274554-sprint-jumps-3_2-on-report-of-t-mobile-merger-prep\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint jumps 3.2% on report of T-Mobile merger prep</a></h4><ul>   <li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) has spiked suddenly to its high of the day, <font color='green'>up 3.2%</font>, on a report in Germany that T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) is preparing its merger plan.</li>    <li>T-Mobile has seen a similar rise, cutting losses and heading into the green, <font color='green'>up 0.1%</font>.</li>    <li>German-language business paper Handelsblatt is reporting the two are prepping a merger plan (<a href=\"https://www.handelsblatt.com/my/unternehmen/it-medien/deutsche-telekom-prueft-fusion-mit-sprint-hoettges-greift-in-amerika-an/19949808.html\" target=\"_blank\">story in German</a>).</li><li>The merger is said to be planned as a paper deal, all stock with no cash flows, with corporate management centered at Deutsche Telekom (<a href='https://seekingalpha.com/symbol/DTEGY' title='Deutsche Telekom AG ADR'>OTCQX:DTEGY</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274554\" data-linked=\"Sprint jumps 3.2% on report of T-Mobile merger prep\" data-tweet=\"$S $S $TMUS - Sprint jumps 3.2% on report of T-Mobile merger prep https://seekingalpha.com/news/3274554-sprint-jumps-3_2-on-report-of-t-mobile-merger-prep?source=tweet\" data-url=\"https://seekingalpha.com/news/3274554-sprint-jumps-3_2-on-report-of-t-mobile-merger-prep\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274549\" data-ts=\"1497975860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPEX\" target=\"_blank\">SPEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274549-spherix-takes-controlling-interest-in-hoth-therapeutics-shares-ahead-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spherix takes controlling interest in Hoth Therapeutics; shares ahead 6%</a></h4><ul><li>Spherix (<a href='https://seekingalpha.com/symbol/SPEX' title='Spherix Incorporated'>SPEX</a> <font color='green'>+5.5%</font>) <a href=\"https://seekingalpha.com/pr/16866344-spherix-inc-announces-definitive-terms-reached-acquire-controlling-interest-hoth-therapeutics\" target=\"_blank\">inks a deal</a> with privately held Hoth Therapeutics to acquire a controlling interest in the dermatology products developer. The transaction should close in ~30 days. Financial terms are not disclosed.</li><li>Hoth is leveraging its BioLexa platform to develop non-steroid drugs to treat skin disorders like eczema.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274549\" data-linked=\"Spherix takes controlling interest in Hoth Therapeutics; shares ahead 6%\" data-tweet=\"$SPEX - Spherix takes controlling interest in Hoth Therapeutics; shares ahead 6% https://seekingalpha.com/news/3274549-spherix-takes-controlling-interest-in-hoth-therapeutics-shares-ahead-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3274549-spherix-takes-controlling-interest-in-hoth-therapeutics-shares-ahead-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274548\" data-ts=\"1497975760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNI\" target=\"_blank\">SSNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274548-silver-spring-networksplus-5-guggenheim-initiates-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silver Spring Networks +5% as Guggenheim initiates at Buy</a></h4><ul>   <li>Silver Spring Networks (NYSE:<a href='https://seekingalpha.com/symbol/SSNI' title='Silver Spring Networks'>SSNI</a>) is <font color='green'>up 5%</font> and at its highest point in six weeks after a Guggenheim launch at Buy.</li>    <li>The company has a \"considerable\" backlog of orders and is a bargain after recent weakness, Guggenheim says, though it's still a \"show me\" story with a new management team.</li>    <li>Shares are <font color='red'>down 17.1%</font> YTD.</li>    <li>Guggenheim has a price target of $13, implying 18% upside from today's higher price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274548\" data-linked=\"Silver Spring Networks +5% as Guggenheim initiates at Buy\" data-tweet=\"$SSNI - Silver Spring Networks +5% as Guggenheim initiates at Buy https://seekingalpha.com/news/3274548-silver-spring-networksplus-5-guggenheim-initiates-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3274548-silver-spring-networksplus-5-guggenheim-initiates-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274547\" data-ts=\"1497975584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274547-consumer-top-gainers-losers-of-12-20-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:20 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274547\" data-linked=\"Consumer - Top Gainers / Losers as of 12:20 pm\" data-tweet=\"$SGOC $JAKK $CELH - Consumer - Top Gainers / Losers as of 12:20 pm https://seekingalpha.com/news/3274547-consumer-top-gainers-losers-of-12-20-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3274547-consumer-top-gainers-losers-of-12-20-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274538\" data-ts=\"1497974358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274538-iron-ore-forecast-in-low-40s-citi-analysts-supply-keeps-growing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iron ore forecast in low $40s by Citi analysts as supply keeps growing</a></h4><ul>     <li><a href=\"https://www.bloomberg.com/news/articles/2017-06-19/iron-seen-in-low-40s-by-citigroup-as-supply-grows-demand-peaks\" target=\"_blank\">Iron ore prices may extend their slump</a> and move into the low $40s/metric ton over the next 6-8 months, Citigroup says, after already sinking by more than a third since rising to nearly $95 in February as a global supply glut increases.</li>     <li>Citi sees iron ore at $51/metric ton in Q3 compared with a previous estimate of $64, and at $48/metric ton in Q4 vs. its earlier outlook for $60.</li>     <li>The pullback in iron ore is in contrast to surging prices of steel reinforcement bar, and Citigroup estimates that mills have ramped up output to a maximum because of the robust margins.</li>     <li>Citi forecasts an iron ore surplus of 118M tons in 2017 after a glut of more than 60M tons last year, with ongoing expansion by large miners, notably Vale&rsquo;s (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-3.5%</font>) S11D project and Roy Hill, likely contributing ~60M tons of additional supply this year.</li>     <li>Citi <a href=\"http://www.barrons.com/articles/iron-ore-citi-cuts-forecasts-warns-prices-will-fall-below-50-downgrades-fortescue-to-sell-1497860475\" target=\"_blank\">cuts its stock price targets</a> for BHP&nbsp;Billiton (<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='red'>-3.6%</font>) and Rio Tinto (<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='red'>-3.4%</font>) while keeping Buy ratings on both, but it cuts Fortescue Metals (<a href='https://seekingalpha.com/symbol/FSUMF' title='Fortescue Metals Group Ltd'>OTCQX:FSUMF</a> <font color='green'>+0.3%</font>) to Sell from Neutral, saying the company faces a &ldquo;double whammy&rdquo; of lower prices and higher discounts for low-grade products.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274538\" data-linked=\"Iron ore forecast in low $40s by Citi analysts as supply keeps growing\" data-tweet=\"$VALE $VALE $BHP - Iron ore forecast in low $40s by Citi analysts as supply keeps growing https://seekingalpha.com/news/3274538-iron-ore-forecast-in-low-40s-citi-analysts-supply-keeps-growing?source=tweet\" data-url=\"https://seekingalpha.com/news/3274538-iron-ore-forecast-in-low-40s-citi-analysts-supply-keeps-growing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274534\" data-ts=\"1497973545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274534-instagram-stories-hits-250m-daily-users-snapminus-2_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Instagram Stories hits 250M daily users; Snap -2.9%</a></h4><ul>   <li>Just two months after rushing to the 200M-user mark and <a href=\"https://seekingalpha.com/news/3257086-instagram-stories-sees-200m-daily-users-surpassing-snapchat\" target=\"_blank\">passing Snapchat</a> (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) in daily users, Instagram Stories (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) now says it's <a href=\"http://www.cnbc.com/2017/06/20/instagram-crushes-snapchats-daily-active-users-rate.html\" target=\"_blank\">hit 250M daily users</a>.</li>    <li>In that period Instagram Stories (which has aped Snapchat's previously distinctive disappearing-stories feature) has added about 50M users, while Snap hit 166M in May after reaching about 161M in March.</li>    <li>Instagram added its Stories feature in August 2016 and has grown very rapidly since.</li>    <li>Snap is sliding anew, <font color='red'>down 2.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274534\" data-linked=\"Instagram Stories hits 250M daily users; Snap -2.9%\" data-tweet=\"$SNAP $SNAP $FB - Instagram Stories hits 250M daily users; Snap -2.9% https://seekingalpha.com/news/3274534-instagram-stories-hits-250m-daily-users-snapminus-2_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3274534-instagram-stories-hits-250m-daily-users-snapminus-2_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274533\" data-ts=\"1497973494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ON\" target=\"_blank\">ON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274533-pacific-crest-downgrades-on-semiconductor-shares-down-3_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Crest downgrades ON Semiconductor; shares down 3.5%</a></h4><ul><li>        Pacific Crest <a href=\"https://www.streetinsider.com/Analyst+Comments/Pacific+Crest+Downgrades+ON+Semiconductor+%28ON%29+to+Sector+Weight/13026001.html\" target=\"_blank\">downgrades</a> ON Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a>) from Overweight to Sector Weight.</li><li>               Analyst Michael McConnell cites signs of double-ordering customers as a correction risk over the next year.&nbsp;</li><li>               Latest analyst standings: 7 Buy, 10 Outperform, 4 Hold, and 1 Underperform.&nbsp;</li><li>               Median price target: $19.&nbsp;</li><li>               ON shares are&nbsp;<font color='red'>down 3.45%</font>. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3274533\" data-linked=\"Pacific Crest downgrades ON Semiconductor; shares down 3.5%\" data-tweet=\"$ON - Pacific Crest downgrades ON Semiconductor; shares down 3.5% https://seekingalpha.com/news/3274533-pacific-crest-downgrades-on-semiconductor-shares-down-3_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3274533-pacific-crest-downgrades-on-semiconductor-shares-down-3_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274531\" data-ts=\"1497972995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFS\" target=\"_blank\">SFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274531-smart-final-storesminus-35-since-amzn-wfm-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smart &amp; Final Stores -35% since AMZN-WFM development</a></h4><ul> <li>Shares of Smart &amp; Final Stores (<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores'>SFS</a> <font color='red'>-6.7%</font>) fall sharply again as sentiment fades on the grocery store operator.</li> <li>Smart &amp; Final is now down 35% since the Amazon-Whole Foods news. Investors seem to be viewing the company as in harm's way of a pricing crunch.</li> <li>SFS hit an all-time low of $8.05 within the last half hour.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3274531\" data-linked=\"Smart &amp; Final Stores -35% since AMZN-WFM development\" data-tweet=\"$SFS - Smart &amp; Final Stores -35% since AMZN-WFM development https://seekingalpha.com/news/3274531-smart-final-storesminus-35-since-amzn-wfm-development?source=tweet\" data-url=\"https://seekingalpha.com/news/3274531-smart-final-storesminus-35-since-amzn-wfm-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274529\" data-ts=\"1497972479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVB\" target=\"_blank\">NAVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274529-navidea-inks-commercialization-deal-in-india-for-tc-99m-tilmanocept-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navidea inks commercialization deal in India for Tc 99m tilmanocept; shares up 7%</a></h4><ul><li>Navidea Biopharmaceuticals (<a href='https://seekingalpha.com/symbol/NAVB' title='Navidea Biopharmaceuticals'>NAVB</a> <font color='green'>+7.2%</font>) perks up on higher volume in response to its <a href=\"https://seekingalpha.com/pr/16866996-navidea-enters-exclusive-license-distribution-agreement-india-sayre-therapeutics\" target=\"_blank\">announcement </a>that it has entered into an exclusive license and distribution agreement with Sayre Therapeutics for the development and commercialization of Tc 99m tilmanocept in India.</li><li>Under the terms of the agreement, Navidea will receive an upfront payment, milestones and double-digit royalties on net sales. Specific financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274529\" data-linked=\"Navidea inks commercialization deal in India for Tc 99m tilmanocept; shares up 7%\" data-tweet=\"$NAVB - Navidea inks commercialization deal in India for Tc 99m tilmanocept; shares up 7% https://seekingalpha.com/news/3274529-navidea-inks-commercialization-deal-in-india-for-tc-99m-tilmanocept-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3274529-navidea-inks-commercialization-deal-in-india-for-tc-99m-tilmanocept-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274526\" data-ts=\"1497971694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274526-novartis-wet-amd-candidate-brolucizumab-matches-eylea-in-late-stage-studies-12-week-dosing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novartis wet AMD candidate brolucizumab matches Eylea in late-stage studies with 12-week dosing; shares ahead 1%</a></h4><ul><li><a href=\"https://www.sec.gov/Archives/edgar/data/1114448/000117184317003696/f6k_062017.htm\" target=\"_blank\">Results </a>from two Phase 3 clinical trials, HAWK and HARRIER, assessing Novartis' (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='green'>+0.8%</font>) brolucizumab (RTH258) for the treatment of neovascular age-related macular degeneration (wet AMD) showed it to be non-inferior to Regeneron Pharmaceuticals (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='green'>+6.9%</font>) and Bayer's (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer A.G. ADR'>OTCPK:BAYRY</a> <font color='red'>-1.3%</font>) EYLEA (aflibercept).</li><li>Brolucizumab, a humanized single-chain antibody fragment with high affinity for all VEGF-A isoforms, showed efficacy over 48 weeks based on one injection every 12 weeks. EYLEA is administered every eight weeks (after a loading phase for both therapies).</li><li>The data analysis is ongoing and will be be submitted for presentation at an upcoming medical conference. The company plans to submit marketing applications in 2018 after completing the pharmacokinetic study with the final manufacturing process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274526\" data-linked=\"Novartis wet AMD candidate brolucizumab matches Eylea in late-stage studies with 12-week dosing; shares ahead 1%\" data-tweet=\"$NVS $NVS $REGN - Novartis wet AMD candidate brolucizumab matches Eylea in late-stage studies with 12-week dosing; shares ahead 1% https://seekingalpha.com/news/3274526-novartis-wet-amd-candidate-brolucizumab-matches-eylea-in-late-stage-studies-12-week-dosing?source=tweet\" data-url=\"https://seekingalpha.com/news/3274526-novartis-wet-amd-candidate-brolucizumab-matches-eylea-in-late-stage-studies-12-week-dosing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274525\" data-ts=\"1497971542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274525-energy-sector-on-track-for-worst-one-day-drop-since-march\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy sector on track for worst one-day drop since March</a></h4><ul><li>U.S. crude oil plunges 3% to $42.85/bbl, hitting its <a href=\"https://seekingalpha.com/news/3274419-quick-drop-brings-oil-new-low-year\" target=\"_blank\">lowest level since mid-November</a> and retreating to <a href=\"http://www.marketwatch.com/story/oil-threatens-to-plunge-into-bear-market-territory-2017-06-20\" target=\"_blank\">bear market territory</a> defined as a drop of at least 20% from a recent peak.</li><li>The fresh leg lower comes on signs of rising output from Nigeria and Libya, two OPEC members currently exempt from cutting supply.</li><li>John Kilduff, founding partner at energy hedge  fund Again Capital, tells CNBC that oil prices \"most definitely\" are <a href=\"http://www.cnbc.com/2017/06/20/oil-prices-are-tumbling-more-than-2-percent-toward-43-a-barrel-right-now.html\" target=\"_blank\">heading to $40</a> and likely into the upper $30s.</li><li>The gloom means the Energy Select Sector SPDR ETF (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='red'>-1.9%</font>) is on pace for its worst daily decline since March 8.</li><li>Oil equities are broadly and sharply lower, including: <a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='red'>-1.4%</font>, <a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-1.6%</font>, <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='red'>-2.1%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='red'>-4.3%</font>, <a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color='red'>-6.2%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color='red'>-4.4%</font>, <a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='red'>-2%</font>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='red'>-2.8%</font>, <a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color='red'>-3.2%</font>, <a href='https://seekingalpha.com/symbol/PSX' title='Phillips 66'>PSX</a> <font color='red'>-2.4%</font>, <a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color='red'>-1.6%</font>, <a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a> <font color='red'>-2.9%</font>, <a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color='red'>-2.1%</font>, <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color='red'>-2%</font>, <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='red'>-8.7%</font>, <a href='https://seekingalpha.com/symbol/KMI' title='Kinder Morgan, Inc.'>KMI</a> <font color='red'>-2.4%</font>, ETP <font color='red'>-4.7%</font>, <a href='https://seekingalpha.com/symbol/EPD' title='Enterprise Products Partners L.P'>EPD</a> <font color='red'>-2.4%</font>, <a href='https://seekingalpha.com/symbol/WMB' title='Williams Companies Inc'>WMB</a> <font color='red'>-2.5%</font>, <a href='https://seekingalpha.com/symbol/SU' title='Suncor Energy Inc.'>SU</a> <font color='red'>-3%</font>, <a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a> <font color='red'>-1.6%</font>, <a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='red'>-11.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274525\" data-linked=\"Energy sector on track for worst one-day drop since March\" data-tweet=\"$XOM $XLE $XOM - Energy sector on track for worst one-day drop since March https://seekingalpha.com/news/3274525-energy-sector-on-track-for-worst-one-day-drop-since-march?source=tweet\" data-url=\"https://seekingalpha.com/news/3274525-energy-sector-on-track-for-worst-one-day-drop-since-march\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>199&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274524\" data-ts=\"1497971432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKD\" target=\"_blank\">BKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274524-brookdale-senior-up-2-after-sale-of-peer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brookdale Senior up 2% after sale of peer</a></h4><ul><li>Extrapolating from <a href=\"http://www.mcknightsseniorliving.com/companies/columbia-pacific-advisors-acquiring-hawthorn-retirement-group/article/669712/\" target=\"_blank\">today's sale of Hawthorn Retirement Group</a>, analyst Frank Morgan and team figure Brookdale Senior (<a href='https://seekingalpha.com/symbol/BKD' title='Brookdale Senior Living Inc.'>BKD</a> <font color='green'>+1.9%</font>) could be worth up to $27 per share in a sale -&nbsp;<font color='green'>80% above&nbsp;</font>the current price.</li><li>A similar valuation equates to $22 per share for BKD, but BKD has other assets like&nbsp;ancillary services, management services, unconsolidated ventures, and leased portfolio which would add another $5.</li><li>Source: Tatiana Darie at Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3274524\" data-linked=\"Brookdale Senior up 2% after sale of peer\" data-tweet=\"$BKD - Brookdale Senior up 2% after sale of peer https://seekingalpha.com/news/3274524-brookdale-senior-up-2-after-sale-of-peer?source=tweet\" data-url=\"https://seekingalpha.com/news/3274524-brookdale-senior-up-2-after-sale-of-peer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274493\" data-ts=\"1497970896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274493-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+75%</font>. <a href='https://seekingalpha.com/symbol/IMMY-OLD' title='Imprimis Pharmaceuticals, Inc.'>IMMY-OLD</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NK' title='NantKwest'>NK</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/CFMS' title='ConforMIS'>CFMS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274493\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$DCTH $IMMY-OLD $IMGN - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3274493-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3274493-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274519\" data-ts=\"1497970766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274519-pacific-crest-reverses-nvidia-downgrade-shares-up-1_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Crest reverses Nvidia downgrade; shares up 1.6%</a></h4><ul><li>        Pacific Crest <a href=\"http://www.cnbc.com/2017/06/20/a-bear-on-the-markets-hottest-stock-nvidia-just-threw-in-the-towel.html\" target=\"_blank\">reverses</a> its April downgrade and pushes Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) from Underweight to Sector Weight due to cryptocurrency mining driving up graphics card demand.</li><li>               Analyst Michael McConnell writes that the Q2 demand would feature a surge from miners in China and Eastern Europe, rather than showing the quarter&rsquo;s typical seasonal weakness.&nbsp;</li><li>               McConnell notes that surveyed graphics card manufacturers expect the demand to last until August at the latest and that a similar surge in 2013 was quickly followed by an inventory correction. &nbsp;&nbsp;</li><li>               Nvidia shares are u<font color='green'>p 1.6%</font>&nbsp;and have rallied over 236% in the past year. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3274519\" data-linked=\"Pacific Crest reverses Nvidia downgrade; shares up 1.6%\" data-tweet=\"$NVDA - Pacific Crest reverses Nvidia downgrade; shares up 1.6% https://seekingalpha.com/news/3274519-pacific-crest-reverses-nvidia-downgrade-shares-up-1_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3274519-pacific-crest-reverses-nvidia-downgrade-shares-up-1_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274512\" data-ts=\"1497969866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCTH\" target=\"_blank\">DCTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274512-delcath-continues-up-move-shares-ahead-75\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delcath continues up move; shares ahead 75%</a></h4><ul><li>Back-from-the-dead Delcath Systems (<a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+75.3%</font>) has been a big winner recently for intrepid investors. Shares are up over 10-fold since early June. The company has yet to prove its percutaneous hepatic perfusion &#40;PHP&#41; technology is a winner. A proposed reverse stock split failed a shareholder vote last week. The company will need a capital raise at some point.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3272446-delcath-annual-meeting-postponed-june-16-allow-shares-voted-reverse-stock-split-proposed\" target=\"_blank\">Delcath annual meeting postponed until June 16 to allow more shares to be voted, reverse stock split proposed; shares ahead 65%</a> (June 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3244851-retrospective-study-shows-treatment-benefit-php-metastatic-ocular-melanoma-patients-delcath\" target=\"_blank\">Retrospective study shows treatment benefit of PHP in metastatic ocular melanoma  patients; Delcath up 46%</a> (Feb. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274512\" data-linked=\"Delcath continues up move; shares ahead 75%\" data-tweet=\"$DCTH - Delcath continues up move; shares ahead 75% https://seekingalpha.com/news/3274512-delcath-continues-up-move-shares-ahead-75?source=tweet\" data-url=\"https://seekingalpha.com/news/3274512-delcath-continues-up-move-shares-ahead-75\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274513\" data-ts=\"1497969743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274513-fitbit-links-up-nbas-timberwolves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit links up with NBA&#39;s Timberwolves</a></h4><ul>   <li>Fitbit (<a href=\"http://seekingalpha.com/symbol/FIT\" target=\"_blank\">FIT</a> <font color='red'>-1.6%</font>) has secured a <a href=\"https://seekingalpha.com/pr/16866790-minnesota-timberwolves-fitbit-announce-multi-year-partnership-naming-company-official\" target=\"_blank\">three-year partnership</a> with the NBA's Minnesota Timberwolves that makes the company's products the \"official wearable\" of the team and provides Fitbit with a number of marketing assets.</li>    <li>That includes the team's first-ever jersey patch, a high-visibility placement on player uniforms, starting with the fall season.</li>    <li>The deal incorporates the Timberwolves as well as WNBA squad the Minnesota Lynx, and Minnesota's new NBA G League team, the Iowa Wolves.</li>    <li>Fitbit will have branding and integration in the team's mobile app as well as signage in the arena, and its team store, and reach into the team's social channels.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274513\" data-linked=\"Fitbit links up with NBA&#39;s Timberwolves\" data-tweet=\"$FIT - Fitbit links up with NBA&#39;s Timberwolves https://seekingalpha.com/news/3274513-fitbit-links-up-nbas-timberwolves?source=tweet\" data-url=\"https://seekingalpha.com/news/3274513-fitbit-links-up-nbas-timberwolves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274510\" data-ts=\"1497969343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274510-rio-tinto-starts-new-exploration-in-mongolian-desert\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rio Tinto starts new exploration in Mongolian desert</a></h4><ul>     <li>Rio Tinto (<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='red'>-3.3%</font>) says it has <a href=\"http://www.reuters.com/article/mongolia-riotinto-idUSL3N1JH3LP\" target=\"_blank\">started new exploration work</a> in Mongolia's Gobi desert outside of its Oyu Tolgoi licenses, following a gap of around five years.</li>     <li>The news is a sign that Mongolia is beginning to bring back foreign investors following a deep economic slump, declining commodity prices and a downturn in coal demand.</li>     <li>Rio has a 66% shareholding in Oyu Tolgoi, a copper and gold mine in the southern Gobi Desert, a stake it holds indirectly through a majority ownership of Turquoise Hill Resources (<a href='https://seekingalpha.com/symbol/TRQ' title='Turquoise Hill Resources Ltd.'>TRQ</a> <font color='red'>-1.4%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274510\" data-linked=\"Rio Tinto starts new exploration in Mongolian desert\" data-tweet=\"$RIO $RIO $TRQ - Rio Tinto starts new exploration in Mongolian desert https://seekingalpha.com/news/3274510-rio-tinto-starts-new-exploration-in-mongolian-desert?source=tweet\" data-url=\"https://seekingalpha.com/news/3274510-rio-tinto-starts-new-exploration-in-mongolian-desert\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274509\" data-ts=\"1497969121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274509-report-snap-nearing-release-of-mapping-feature\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Snap nearing release of mapping feature</a></h4><ul>   <li>Snap (<a href=\"http://seekingalpha.com/symbol/SNAP\" target=\"_blank\">SNAP</a> <font color='red'>-1.7%</font>) is working on a <a href=\"https://www.theinformation.com/snap-eyeing-maps-in-battle-for-location\" target=\"_blank\">mapping feature</a> to come out in coming weeks, according to The Information.</li>    <li>The feature -- internally called \"Snap Maps\" -- would let users pinch out in the app to show a map indicating where people are posting stories nearby and elsewhere, according to four sources.</li>    <li>It's been used in an internal version by employees, according to the report.</li>    <li>Snap shares are giving back some gains today after <font color='green'>rising 2%</font> yesterday in the wake of a <a href=\"https://seekingalpha.com/news/3274284-snap-plus-2_7-percent-time-warner-show-development-deal\" target=\"_blank\">$100M show development deal with Time Warner</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274509\" data-linked=\"Report: Snap nearing release of mapping feature\" data-tweet=\"$SNAP - Report: Snap nearing release of mapping feature https://seekingalpha.com/news/3274509-report-snap-nearing-release-of-mapping-feature?source=tweet\" data-url=\"https://seekingalpha.com/news/3274509-report-snap-nearing-release-of-mapping-feature\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274503\" data-ts=\"1497968370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274503-movie-theater-stocks-sluggish-amid-broad-retail-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Movie theater stocks sluggish amid broad retail concerns</a></h4><ul>     <li>Stocks related to movie theaters are off to a rough start on a down day for retail in general.</li>     <li>On a broad look, the summer box office season has started off relatively disappointing in comparison to estimates, although the YTD box office total is&nbsp;still up <a href=\"http://www.boxofficemojo.com/yearly/?view2=ytdcompare\" target=\"_blank\">2.6%</a>&nbsp;through June 18 over last year's pace.</li>     <li>Decliners: AMC Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a>) <font color='red'>-3.23%</font>, Regal Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a>) <font color='red'>-1.12%</font>, IMAX (NYSE:<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a>) <font color='red'>-1.20%</font>, Cinemark (NYSE:<a href='https://seekingalpha.com/symbol/CNK' title='Cinemark Holdings, Inc'>CNK</a>) <font color='red'>-1.48%</font>, Reading International (NASDAQ:<a href='https://seekingalpha.com/symbol/RDI' title='Reading International, Inc.'>RDI</a>) <font color='red'>-1.01%</font>, Dolby Laboratories (NYSE:<a href='https://seekingalpha.com/symbol/DLB' title='Dolby Laboratories, Inc.'>DLB</a>) <font color='red'>-1.05%</font>.</li>           </ul><div class=\"tiny-share-widget\" data-id=\"3274503\" data-linked=\"Movie theater stocks sluggish amid broad retail concerns\" data-tweet=\"$AMC $AMC $RGC - Movie theater stocks sluggish amid broad retail concerns https://seekingalpha.com/news/3274503-movie-theater-stocks-sluggish-amid-broad-retail-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3274503-movie-theater-stocks-sluggish-amid-broad-retail-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274502\" data-ts=\"1497968353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBSN\" target=\"_blank\">GBSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274502-great-basin-prices-2_7m-equity-offering-shares-down-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Basin prices $2.7M equity offering; shares down 16%</a></h4><ul><li>Great Basin Scientific (<a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a> <font color='red'>-15.8%</font>) <a href=\"https://seekingalpha.com/pr/16866823-great-basin-scientific-prices-2_7-million-registered-offering-units\" target=\"_blank\">prices </a>its offering of 8.9M units that is expected to raise $2.7M in new capital.</li><li>The offering consists of Class &nbsp;A Units and Class B Units priced at $0.30 and $0.29, respectively.</li><li>Each Class A Unit includes one share of common stock and one 60-day Series J Warrant to purchase 2.5 shares of common at $0.30.</li><li>Class B Units are being offered to any buyer whose Class A investment would increase its stake to more than 4.99% or 9.99%, at the buyer's election. Each Class B Unit consists of one pre-funded Series K Warrant and one Series J Warrant.</li><li>Net proceeds should be ~$2M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274502\" data-linked=\"Great Basin prices $2.7M equity offering; shares down 16%\" data-tweet=\"$GBSN $GBSN-OLD - Great Basin prices $2.7M equity offering; shares down 16% https://seekingalpha.com/news/3274502-great-basin-prices-2_7m-equity-offering-shares-down-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3274502-great-basin-prices-2_7m-equity-offering-shares-down-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274498\" data-ts=\"1497966917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOSL\" target=\"_blank\">FOSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274498-fossil-perks-up-after-buckingham-calls-valuatgion-balanced\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fossil perks up after Buckingham calls valuatgion balanced</a></h4><ul> <li>Fossil (<a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+3.6%</font>) moves higher after Buckingham Research upgrades the retailer to Neutral from Underperform as it gauges valuation after a 63% YTD plunge in share price.</li> <li>The firm sees shares now at a balanced risk vs. reward level.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3274498\" data-linked=\"Fossil perks up after Buckingham calls valuatgion balanced\" data-tweet=\"$FOSL - Fossil perks up after Buckingham calls valuatgion balanced https://seekingalpha.com/news/3274498-fossil-perks-up-after-buckingham-calls-valuatgion-balanced?source=tweet\" data-url=\"https://seekingalpha.com/news/3274498-fossil-perks-up-after-buckingham-calls-valuatgion-balanced\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274496\" data-ts=\"1497966822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLT\" target=\"_blank\">EGLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274496-fda-rejects-egalets-marketing-application-for-higher-doses-of-oxaydo-shares-off-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejects Egalet&#39;s marketing application for higher doses of Oxaydo; shares off 8%</a></h4><ul><li>Egalet (<a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='red'>-7.9%</font>) <a href=\"https://seekingalpha.com/pr/16866780-egalet-receives-complete-response-letter-u-s-food-drug-administration-prior-approval\" target=\"_blank\">receives </a>a Complete Response Letter &#40;CRL&#41; from the FDA related to its application to market 10 mg and 15 mg strengths of pain med OXAYDO (oxycodone HCl). It is currently offered in 5 mg and 7.5 mg doses.</li><li>The CRL cites the need for more information on the effect of food on the 15 mg dose and the intranasal abuse-deterrent properties of both doses. The company says it will work with the regulator to address the issues.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3257554-fda-accepts-egalets-pas-oxaydo-10-15-mg-shares-ahead-9-percent-premarket\" target=\"_blank\">FDA accepts Egalet's PAS for OXAYDO 10/15 mg; shares ahead 9% premarket</a> (April 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274496\" data-linked=\"FDA rejects Egalet&#39;s marketing application for higher doses of Oxaydo; shares off 8%\" data-tweet=\"$EGLT $ZCOR - FDA rejects Egalet&#39;s marketing application for higher doses of Oxaydo; shares off 8% https://seekingalpha.com/news/3274496-fda-rejects-egalets-marketing-application-for-higher-doses-of-oxaydo-shares-off-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3274496-fda-rejects-egalets-marketing-application-for-higher-doses-of-oxaydo-shares-off-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274489\" data-ts=\"1497965426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274489-glu-mobileplus-4_4-after-mobile-game-deal-wwe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu Mobile +4.4% after mobile game deal with WWE</a></h4><ul>   <li>Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) is <font color='green'>up 4.4%</font> premarket after word that it's <a href=\"https://seekingalpha.com/pr/16866319-glu-wwe-partner-development-upcoming-mobile-game\" target=\"_blank\">collaborating with World Wrestling Entertainment</a> (NYSE:<a href='https://seekingalpha.com/symbol/WWE' title='World Wrestling Entertainment, Inc.'>WWE</a>) on a upcoming game.</li>    <li>The two have a multi-year deal to make a mobile game that features WWE's wrestlers, logos and marks via the same studio that makes Glu's biggest sports franchise, <i>Tap Sports Baseball.</i></li><li>The game's set for a 2018 release.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274489\" data-linked=\"Glu Mobile +4.4% after mobile game deal with WWE\" data-tweet=\"$GLUU $GLUU $WWE - Glu Mobile +4.4% after mobile game deal with WWE https://seekingalpha.com/news/3274489-glu-mobileplus-4_4-after-mobile-game-deal-wwe?source=tweet\" data-url=\"https://seekingalpha.com/news/3274489-glu-mobileplus-4_4-after-mobile-game-deal-wwe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274484\" data-ts=\"1497965106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274484-comcastminus-1_9-moffettnathanson-goes-neutral-after-run\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast -1.9% as MoffettNathanson goes Neutral after run</a></h4><ul>   <li>Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) is making a rare premarket move down, <font color='red'>1.9% lower</font>, as MoffettNathanson downgrades it to Neutral along with other cablecos.</li>    <li>At $41.80, The stock is just 7% below the firm's target price of $45, MoffettNathanson notes.</li>    <li>Cable stock prices have risen so much in the past years that \"the room for a differentiated upside forecast\" is narrower, the firm says. \"That the cable companies are very, very good businesses is no longer a secret.\"</li>    <li>Comcast is <font color='green'>up 21.1%</font> this year alone; it's <font color='green'>risen 169%</font> over the past five years.</li><li>Charter (NASDAQ:<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a>) is <font color='red'>0.7% lower</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274484\" data-linked=\"Comcast -1.9% as MoffettNathanson goes Neutral after run\" data-tweet=\"$CMCSA $CMCSA $CHTR - Comcast -1.9% as MoffettNathanson goes Neutral after run https://seekingalpha.com/news/3274484-comcastminus-1_9-moffettnathanson-goes-neutral-after-run?source=tweet\" data-url=\"https://seekingalpha.com/news/3274484-comcastminus-1_9-moffettnathanson-goes-neutral-after-run\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274480\" data-ts=\"1497964905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274480-ford-updates-on-production-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford updates on production plans</a></h4><ul>     <li>Ford (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) <a href=\"https://seekingalpha.com/pr/16866706-ford-invests-kentucky-plant-build-new-expedition-navigator-smart-spacious-new-focus-n\" target=\"_blank\">announces</a> it will invest $900M in a truck plant in Kentucky that builds the Expedition and Lincoln Navigator models.</li>     <li>The company notes that it exports the two truck lines to over 55 global markets.</li>     <li>A next-gen Ford Focus is expected to be sourced primarily out of China in the second half of 2019 to help the automaker save costs and improve its manufacturing scale in China. No hourly U.S. jobs will be cut due to the manufacturing plan for the Focus model. The Michigan plant that currently produces Focus cars will start pumping out Ranger trucks and Bronco SUVs.</li>     <li>\"Finding a more cost-effective way to deliver the next Focus program in North America is a better plan, allowing us to redeploy the money we save into areas of growth for the company &ndash; especially sport utilities, commercial vehicles, performance vehicles as well as mobility, autonomous vehicles and electrified vehicles,\" says Ford exec Joe Hinrichs.</li>      <li>The new plan for Focus production is expected to help Ford save $1B in investments costs compared to the original plan.</li>    <li>Shares of Ford <font color='red'>fell 0.18%</font> premarket to $11.22.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274480\" data-linked=\"Ford updates on production plans\" data-tweet=\"$F - Ford updates on production plans https://seekingalpha.com/news/3274480-ford-updates-on-production-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3274480-ford-updates-on-production-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>109&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274477\" data-ts=\"1497964448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274477-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a>&nbsp;<font color='green'>+30%</font>&nbsp;on&nbsp;announcement&nbsp;that it plans to resubmit its New Drug Application &#40;NDA&#41; to the FDA next quarter for testosterone replacement therapy candidate LPCN 1021</li><li><a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='green'>+11%</font>.</li><li><a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='green'>+7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274477\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$LPCN $RWLK $VSLR - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3274477-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3274477-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274475\" data-ts=\"1497964190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274475-jittery-trading-on-barnes-noble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jittery trading on Barnes &amp; Noble</a></h4><ul> <li>Investors are bailing on Barnes &amp; Noble (NYSE:<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a>) in front of the company's FQ4 earnings report due out Thursday.</li> <li>The retail company is expected to post revenue of $778M and a loss of $0.17 per share.</li> <li>Also in the background is the Amazon acquisition of Whole Foods and the ensuing guessing game on which retailers won't survive the e-commerce onslaught.</li> <li>Shares of Barnes &amp; Noble are <font color='red'>down 5.11%</font> premarket to $6.50. The 52-week low on B&amp;N is $6.45.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3274475\" data-linked=\"Jittery trading on Barnes &amp; Noble\" data-tweet=\"$BKS - Jittery trading on Barnes &amp; Noble https://seekingalpha.com/news/3274475-jittery-trading-on-barnes-noble?source=tweet\" data-url=\"https://seekingalpha.com/news/3274475-jittery-trading-on-barnes-noble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274474\" data-ts=\"1497964045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFUN\" target=\"_blank\">SFUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274474-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Limited'>SFUN</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3274424-fang-holdings-misses-0_01-misses-revenue\" target=\"_blank\">Q1 earnings</a> miss.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3274474\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$SFUN - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3274474-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3274474-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274468\" data-ts=\"1497963673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDUS\" target=\"_blank\">FDUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274468-fidus-upsizes-capital-raise-shares-down-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fidus upsizes capital raise; shares down 3% premarket</a></h4><ul><li>Fidus Investment (NASDAQ:<a href='https://seekingalpha.com/symbol/FDUS' title='Fidus Investment'>FDUS</a>) ended <a href=\"https://seekingalpha.com/pr/16866563-fidus-investment-corporation-prices-public-offering-common-stock\" target=\"_blank\">up selling 1.75M shares</a> (vs. 1.5M originally planned) for $16.80 each. Net proceeds are seen at about $28M.<br>The underwriters have an option to buy up to another 262.5K shares at that price.</li><li>The stock's&nbsp;<font color='red'>down 3.1%&nbsp;</font>premarket to $16.71. March 31 book value per share was $15.80.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274468\" data-linked=\"Fidus upsizes capital raise; shares down 3% premarket\" data-tweet=\"$FDUS - Fidus upsizes capital raise; shares down 3% premarket https://seekingalpha.com/news/3274468-fidus-upsizes-capital-raise-shares-down-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3274468-fidus-upsizes-capital-raise-shares-down-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274462\" data-ts=\"1497963134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISR\" target=\"_blank\">ISR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274462-isorays-cesiumminus-131-brachytherapy-shows-positive-effect-in-single-site-study-shares-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IsoRay&#39;s Cesium-131 brachytherapy shows positive effect in single-site study; shares ahead 9% premarket</a></h4><ul><li>Thinly traded nano cap IsoRay (NYSEMKT:<a href='https://seekingalpha.com/symbol/ISR' title='IsoRay, Inc.'>ISR</a>) perks up<font color='green'> 9%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16866352-isoray-announces-study-published-international-journal-radiation-oncology-biology-physics\" target=\"_blank\">announcement </a>results from a study performed at NY Presbyterian Hospital assessing low-dose Cesium-131 brachytherapy in brain cancer patients.</li><li>Results from 42 patients with 46 metastases at least 2 cm in diameter who underwent surgical resection showed no regrowth of their tumors after the intra-operative placement of stranded Cesium-131 seeds into the resection cavity. There were also no cases of radionecrosis observed, a significant unwanted side effect of radiation therapy to the brain.</li><li>The study was just published in International <em>Journal of Radiation Oncology, Biology, Physics.</em></li></ul><div class=\"tiny-share-widget\" data-id=\"3274462\" data-linked=\"IsoRay&#39;s Cesium-131 brachytherapy shows positive effect in single-site study; shares ahead 9% premarket\" data-tweet=\"$ISR - IsoRay&#39;s Cesium-131 brachytherapy shows positive effect in single-site study; shares ahead 9% premarket https://seekingalpha.com/news/3274462-isorays-cesiumminus-131-brachytherapy-shows-positive-effect-in-single-site-study-shares-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3274462-isorays-cesiumminus-131-brachytherapy-shows-positive-effect-in-single-site-study-shares-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274459\" data-ts=\"1497962667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PERF\" target=\"_blank\">PERF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274459-perfumania-spikes-nussdorf-family-weighs-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perfumania spikes as Nussdorf family weighs options</a></h4><ul> <li>The Nussdorf family is looking at alternatives with the capital structure of Perfumania Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PERF' title='Perfumania Holdings, Inc'>PERF</a>), according to a filing by the company.</li> <li>The options being considered include payments by Perfumania of up to $2.00 per share to shareholders in a restructuring scenario.</li> <li><a href=\"https://seekingalpha.com/filing/3598879\" target=\"_blank\">SEC Form 13D</a></li> <li>Shares of Perfumania are <font color='green'>up 21.53%</font> to $1.75.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3274459\" data-linked=\"Perfumania spikes as Nussdorf family weighs options\" data-tweet=\"$PERF - Perfumania spikes as Nussdorf family weighs options https://seekingalpha.com/news/3274459-perfumania-spikes-nussdorf-family-weighs-options?source=tweet\" data-url=\"https://seekingalpha.com/news/3274459-perfumania-spikes-nussdorf-family-weighs-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274452\" data-ts=\"1497961996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYD\" target=\"_blank\">BYD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274452-morgan-stanley-sees-valuation-peak-for-boyd-gaming\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley sees valuation peak for Boyd Gaming</a></h4><ul> <li>Boyd Gaming (NYSE:<a href='https://seekingalpha.com/symbol/BYD' title='Boyd Gaming Corporation'>BYD</a>) is on watch after Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Downgrades+Boyd+Gaming+%28BYD%29+to+Equalweight/13026116.html\" target=\"_blank\">downgrades</a> shares to Equalweight from Overweight on a call tied to valuation.</li> <li>Shares of Boyd Gaming are up 27.3% YTD and reached a high of $26.20. Boyd is <font color='red'>down 1.17%</font> premarket to $25.38.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3274452\" data-linked=\"Morgan Stanley sees valuation peak for Boyd Gaming\" data-tweet=\"$BYD - Morgan Stanley sees valuation peak for Boyd Gaming https://seekingalpha.com/news/3274452-morgan-stanley-sees-valuation-peak-for-boyd-gaming?source=tweet\" data-url=\"https://seekingalpha.com/news/3274452-morgan-stanley-sees-valuation-peak-for-boyd-gaming\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274448\" data-ts=\"1497961646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274448-northcoast-jumps-in-after-costco-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northcoast jumps in after Costco slide</a></h4><ul> <li>Northcoast Research upgrades Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) to a Buy rating after watching shares peel back 9% since Amazon nabbed Whole Foods.</li> <li>\"Costco's ability to take market share in fresh food categories has shown it to be relatively immune to food deflation over the past several quarters,\" says analysts Chuck Cerankosky.</li> <li>Northcoast's price target of $190 is 33.3X the firm's 2017 EPS estimate and 29.2X the 2018 EPS estimate. The PT is also above Costco's all-time high of $183.18.</li> <li>COST <font color='green'>+0.49%</font> premarket to $165.15.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3274448\" data-linked=\"Northcoast jumps in after Costco slide\" data-tweet=\"$COST - Northcoast jumps in after Costco slide https://seekingalpha.com/news/3274448-northcoast-jumps-in-after-costco-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/3274448-northcoast-jumps-in-after-costco-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274444\" data-ts=\"1497961638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPCN\" target=\"_blank\">LPCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274444-lipocine-set-to-resubmit-u-s-marketing-application-for-testosterone-replacement-therapy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lipocine set to resubmit U.S. marketing application for testosterone replacement therapy candidate LPCN 1021; shares ahead 28% premarket</a></h4><ul><li>Thinly traded nano cap Lipocine (NASDAQ:<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a>) jumps&nbsp;<font color='green'>28%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16865792-lipocine-validates-titration-dosing-regimen-positive-topline-efficacy-results-lpcn-1021-oral\" target=\"_blank\">announcement </a>that it plans to resubmit its New Drug Application &#40;NDA&#41; to the FDA next quarter for testosterone replacement therapy candidate LPCN 1021.</li><li>The company received a CRL in June 2016 citing deficiencies in the dosing regimen. The agency requested a new clinical trial to validate the regimen before resubmission.</li><li>Results from dosing validation and dosing flexibility studies confirmed that a more practical fixed-dose approach will work, eliminating the need for titration.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3214270-lipocine-meets-fda-discuss-crl-new-clinical-trial-needed-validate-dosing-regimen-lpcn-1021\" target=\"_blank\">Lipocine meets with FDA to discuss CRL, new clinical trial needed to validate dosing regimen of LPCN 1021; shares ahead 12% premarket</a> (Oct. 17, 2016)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3190874-lipocine-bearish-fda-decision-testosterone-pill-shares-12-percent\" target=\"_blank\">Lipocine bearish before FDA decision on testosterone pill; shares down 12%</a> (June 28, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274444\" data-linked=\"Lipocine set to resubmit U.S. marketing application for testosterone replacement therapy candidate LPCN 1021; shares ahead 28% premarket\" data-tweet=\"$LPCN - Lipocine set to resubmit U.S. marketing application for testosterone replacement therapy candidate LPCN 1021; shares ahead 28% premarket https://seekingalpha.com/news/3274444-lipocine-set-to-resubmit-u-s-marketing-application-for-testosterone-replacement-therapy?source=tweet\" data-url=\"https://seekingalpha.com/news/3274444-lipocine-set-to-resubmit-u-s-marketing-application-for-testosterone-replacement-therapy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274442\" data-ts=\"1497961465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOLX\" target=\"_blank\">HOLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274442-fda-clears-hologics-aptima-assay-to-detect-hsv-1-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Hologic&#39;s Aptima assay to detect HSV 1 &amp; 2</a></h4><ul><li>Hologic (NASDAQ:<a href='https://seekingalpha.com/symbol/HOLX' title='Hologic, Inc.'>HOLX</a>) <a href=\"https://seekingalpha.com/pr/16866291-hologic-announces-fda-clearance-aptima-assay-detect-herpes-simplex-virus-1-and-2\" target=\"_blank\">announces</a> that it has obtained FDA clearance to market the <a href=\"http://www.hologic.com/products/clinical-diagnostics/assays-and-tests/aptima-hsv-1-2-assay\" target=\"_blank\">Aptima Herpes Simplex Virus</a> &#40;HSV&#41; 1 &amp; 2 molecular assay on the fully automated <a href=\"http://www.hologic.com/products/clinical-diagnostics/instrument-systems/panther-system\" target=\"_blank\">Panther system</a>. The test will be commercially available in the 50&nbsp;U.S. territories and Puerto Rico.</li>                  <li>The Aptima HSV 1 &amp; 2 assay can be used to qualitatively detect, and differentiate between, HSV-1 and HSV-2.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket on light volume.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3274442\" data-linked=\"FDA clears Hologic&#39;s Aptima assay to detect HSV 1 &amp; 2\" data-tweet=\"$HOLX - FDA clears Hologic&#39;s Aptima assay to detect HSV 1 &amp; 2 https://seekingalpha.com/news/3274442-fda-clears-hologics-aptima-assay-to-detect-hsv-1-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3274442-fda-clears-hologics-aptima-assay-to-detect-hsv-1-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274445\" data-ts=\"1497961428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274445-enphase-energyplus-19-on-flextronics-license-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enphase Energy +19% on Flextronics license agreement</a></h4><ul>     <li>Enphase Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a>)&nbsp;<font color='green'>+19%</font> premarket after disclosing that it <a href=\"https://seekingalpha.com/filing/3598485\" target=\"_blank\">signed a master license agreement</a> with Flextronics (NASDAQ:<a href='https://seekingalpha.com/symbol/FLEX' title='Flex Ltd..'>FLEX</a>), allowing FLEX to market, manufacture and sell certain ENPH products.</li>     <li>FLEX has been an ENPH microinverter manufacturing partner since 2009.</li>     <li>The announcement provides no further details, but it is enough for Deutsche Bank to <a href=\"http://thefly.com/thestreet/realmoney/index.php/ENPHid2568749/ENPH-Enphase-Energy-upgraded-to-Hold-from-Sell-at-Deutsche-Bank\" target=\"_blank\">upgrade</a> ENPH to Hold from Sell with a $1 price target.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274445\" data-linked=\"Enphase Energy +19% on Flextronics license agreement\" data-tweet=\"$ENPH $ENPH $FLEX - Enphase Energy +19% on Flextronics license agreement https://seekingalpha.com/news/3274445-enphase-energyplus-19-on-flextronics-license-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3274445-enphase-energyplus-19-on-flextronics-license-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274436\" data-ts=\"1497960404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274436-jefferies-bullish-on-goodyear-tire-rubber\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies bullish on Goodyear Tire &amp; Rubber</a></h4><ul> <li>Jefferies <a href=\"http://www.cnbc.com/2017/06/20/early-movers-mcd-bcs-tsla-cmg-more.html\" target=\"_blank\">upgrades</a> Goodyear Tire &amp; Rubber (NYSE:<a href='https://seekingalpha.com/symbol/GT' title='Goodyear Tire & Rubber Co.'>GT</a>) to a Buy rating after having it lined up at Hold.</li> <li>The investment firm points to the improved volume numbers from Goodyear and the strong cash returns.</li> <li>Shares of Goodyear are&nbsp;<font color='green'>up 1.10%</font>&nbsp;premarket to $34.00 vs. a 52-week trading range of $24.31 to $37.20.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3274436\" data-linked=\"Jefferies bullish on Goodyear Tire &amp; Rubber\" data-tweet=\"$GT - Jefferies bullish on Goodyear Tire &amp; Rubber https://seekingalpha.com/news/3274436-jefferies-bullish-on-goodyear-tire-rubber?source=tweet\" data-url=\"https://seekingalpha.com/news/3274436-jefferies-bullish-on-goodyear-tire-rubber\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274435\" data-ts=\"1497960381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLPG\" target=\"_blank\">GLPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274435-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Galapagos NV (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a>) initiated with Buy rating and $98 (20% upside) price target by BTIG Research. Shares are down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume.</li><li>Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>) upgraded to Buy with a $107 (22% upside) price target by Janney Capital. Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li><li>Healthcare Trust (NYSE:<a href='https://seekingalpha.com/symbol/HTA' title='Healthcare Trust of America, Inc.'>HTA</a>) upgraded to Outperform with a $35 (9% upside) price target.</li><li>CareTrust REIT (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRE' title='CareTrust REIT'>CTRE</a>) downgraded to Market Perform with a $20 (3% upside) price target by BMO.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274435\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$GLPG $GLPG $CLVS - Premarket analyst action - healthcare https://seekingalpha.com/news/3274435-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3274435-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274426\" data-ts=\"1497959085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNGA\" target=\"_blank\">MNGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274426-magnegas-aims-for-facility-relationships\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MagneGas aims for more facility relationships</a></h4><ul><li>MagneGas (NASDAQ:<a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a>) <font color='green'>+3.3%</font> premarket after <a href=\"https://seekingalpha.com/pr/16866200-magnegas-expands-industrial-gas-and-welding-supply-business-executive-sales-team-appointment\" target=\"_blank\">hiring</a> a key sales executive from a Fortune 500 supply chain solutions company.</li><li>The executive is anticipated to bring up to 80 distinct automotive fabrication and manufacturing facility relationships to MagneGas over the next two to three years.</li><li>It's also estimated that these facilities have an annual spend on such goods of $75K to $100K each.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274426\" data-linked=\"MagneGas aims for more facility relationships\" data-tweet=\"$MNGA $TRNX - MagneGas aims for more facility relationships https://seekingalpha.com/news/3274426-magnegas-aims-for-facility-relationships?source=tweet\" data-url=\"https://seekingalpha.com/news/3274426-magnegas-aims-for-facility-relationships\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274425\" data-ts=\"1497959022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274425-rio-tinto-chooses-2_45b-yancoal-offer-for-coal-mines-over-glencore-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rio Tinto chooses $2.45B Yancoal offer for coal mines over Glencore bid</a></h4><ul>     <li>Rio Tinto (NYSE:<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a>) says it <a href=\"https://www.bloomberg.com/news/articles/2017-06-20/rio-tinto-picks-yancoal-offer-for-coal-mines-over-glencore-bid\" target=\"_blank\">backs the improved offer</a> by China&rsquo;s Yancoal (<a href='https://seekingalpha.com/symbol/YACAF' title='Yancoal Australia Ltd'>OTC:YACAF</a>, <a href='https://seekingalpha.com/symbol/YZC' title='Yanzhou Coal Mining Co. Ltd.'>YZC</a>) for its Australian coal mines, snubbing a <a href=\"https://seekingalpha.com/news/3272711-glencore-crashes-chinese-deal-rio-tintos-australian-coal-2_5b-bid\" target=\"_blank\">last-minute bid</a> from  Glencore (<a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a>).</li>     <li>Even though the price is $100M lower than Glencore&rsquo;s $2.55B bid, Rio says the likelihood of regulatory approval and funding certainty make Yancoal a better choice.</li>     <li>The deal would make Yancoal, which is 13% owned by commodity trading giant Noble Group (<a href='https://seekingalpha.com/symbol/NOBGF' title='NOBLE GROUP LTD ORD NEW'>OTCPK:NOBGF</a>), Australia&rsquo;s largest pure-play coal producer.</li>     <li>Rio shareholders will vote on the deal this month, and the company expects the sale to be completed in Q3.</li><li>RIO <font color='red'>-1.5%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274425\" data-linked=\"Rio Tinto chooses $2.45B Yancoal offer for coal mines over Glencore bid\" data-tweet=\"$RIO $RIO $YACAF - Rio Tinto chooses $2.45B Yancoal offer for coal mines over Glencore bid https://seekingalpha.com/news/3274425-rio-tinto-chooses-2_45b-yancoal-offer-for-coal-mines-over-glencore-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3274425-rio-tinto-chooses-2_45b-yancoal-offer-for-coal-mines-over-glencore-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274423\" data-ts=\"1497958890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEOS\" target=\"_blank\">NEOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274423-fda-oks-neos-therapeutics-adhd-med-cotempla-xr-odt-shares-ahead-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Neos Therapeutics&#39; ADHD med Cotempla XR-ODT; shares ahead 5% premarket</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/16865961-neos-therapeutics-announces-fda-approval-cotempla-xr-odt-methylphenidate-extended-release\" target=\"_blank\">approves</a> Neos Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a>) Cotempla XR-ODT, a methylphenidate extended-release orally disintegrating tablet, for the treatment of attention deficit/hyperactivity disorder &#40;ADHD&#41; in patients six to 17 years old.</li><li>The product, along with Adzenys XR-ODT, are Schedule II controlled substances with high potential for abuse and dependence. Cotempla will be commercially available in the fall.</li><li>Shares are up&nbsp;<font color='green'>5%</font>&nbsp;premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274423\" data-linked=\"FDA OKs Neos Therapeutics&#39; ADHD med Cotempla XR-ODT; shares ahead 5% premarket\" data-tweet=\"$NEOS - FDA OKs Neos Therapeutics&#39; ADHD med Cotempla XR-ODT; shares ahead 5% premarket https://seekingalpha.com/news/3274423-fda-oks-neos-therapeutics-adhd-med-cotempla-xr-odt-shares-ahead-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3274423-fda-oks-neos-therapeutics-adhd-med-cotempla-xr-odt-shares-ahead-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274420\" data-ts=\"1497958415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274420-instinet-lowers-targets-on-chipotle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Instinet lowers targets on Chipotle</a></h4><ul> <li>Instinet lowers its price target on Neutral-rated Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) to $480 from $510. The PT works out to 54.9X the estimate for 2017 EPS and 37.6X the estimate for 2018 EPS.</li> <li>The firm thinks Chipotle will need to make continued investments to drive top line growth and sees margin pressure continuing to linger.</li> <li>Source: Reuters Morning Call</li> <li>Shares of Chipotle are <font color='red'>down 2.16%</font> premarket to $449.00.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3274420\" data-linked=\"Instinet lowers targets on Chipotle\" data-tweet=\"$CMG - Instinet lowers targets on Chipotle https://seekingalpha.com/news/3274420-instinet-lowers-targets-on-chipotle?source=tweet\" data-url=\"https://seekingalpha.com/news/3274420-instinet-lowers-targets-on-chipotle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}